OMCL - オムニセル （Omnicell Inc.） オムニセルOMCLのチャート
OMCLの企業情報
| symbol | OMCL |
|---|---|
| 会社名 | Omnicell Inc （オムニセル） |
| 分野（sector） | Technology ハイテク |
| 産業（industry） | Computer Manufacturing |
| 業種 | 先端医療機器_テクノロジ― IT・通信（IT_Communications） |
| 概要 | 事業概要 オムニセル（Omnicell Inc.）は急性期ケア病院の設定から急性期後の熟練した看護と長期ケア施設から家庭へ至るまで、患者中心の投薬及び供給管理のための自動化とビジネス分析ソフトウェアソリューションを提供する。同社は2つの事業を運営する。自動化・分析部門は、投薬・供給分配システム、薬局在庫管理システム及び関連ソフトウェアの設計、製造、販売およびサービス提供に従事する。投薬遵守部門には、消耗薬ブリスターカード、包装機器、薬物同期プラットフォーム、補助的な製品及びサービスの開発、製造、販売が含まれる。同社の製品は、病院環境の外で投薬管理を管理するために使用され、「MTS」、「Surgichem」、「SureMed」、「Omnicell」ブランドのブランド名で販売されている薬物服用製品が含まれる。 オムニセルは、米国の医療関連サ―ビス会社。おもに投薬管理プロセスや医療品管理の合理化を手掛ける。医療施設での薬や医療・外科用品の取得、管理、調剤を有効に行うために、病院や長期ケア環境における自動化・分析・服薬順守ソリュ―ションを提供する。製品とサ―ビスを、病院と病院以外のヘルスケア施設に販売する。 Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. |
| 本社所在地 | 590 East Middlefield Road Mountain View CA 94043 USA |
| 代表者氏名 | Randall A. Lipps ランダルA.リップス |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 650-251-6100 |
| 設立年月日 | 33848 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2001年 |
| 従業員数 | 2350人 |
| url | www.omnicell.com |
| nasdaq_url | https://www.nasdaq.com/symbol/omcl |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 84.09100 |
| 終値（lastsale） | 65.895 |
| 時価総額（marketcap） | 2587694673.15 |
| 時価総額 | 時価総額（百万ドル） 2478.72 |
| 売上高 | 売上高（百万ドル） 756.01800 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 2631.322 |
| 当期純利益 | 当期純利益（百万ドル） 26.43900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Omnicell Inc. revenues increased 13% to $371.3M. Net income totaled $9.3M vs. loss of $8.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Automation and Analytics segment income increase from $25.7M to $56.3M Medication Adherence segment loss decrease of 7% to $2.1M. |
OMCLのテクニカル分析
OMCLのニュース
Omnicell to cut staff on macro concerns 2022/12/01 13:05:18 Seeking Alpha
Omnicell (OMCL) announced Thursday that the company expects to reduce its headcount by about 9% as part of an ongoing cost-cutting drive that the management is implementing due to…
Can you now get a good deal on Omnicell Inc.’s shares? 2022/11/30 14:48:00 US Post News
In Tuesday’s session, Omnicell Inc. (NASDAQ:OMCL) marked $48.06 per share, down from $48.63 in the previous session. While Omnicell Inc. has underperformed by -1.17%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OMCL fell by -72.85%, with highs and lows ranging from $185.28 to $46.19, whereas […]
Omnicell to cut 9% staff, shares gain 2022/11/30 14:29:06 Investing.com
https://www.investing.com/news/stock-market-news/omnicell-to-cut-9-staff-shares-gain-432SI-2954623
Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference 2022/11/23 21:01:00 Business Wire
SANTA CLARA, Calif.--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference
5 Most Volatile Stocks to Buy Now 2022/11/21 18:38:40 Insider Monkey
In this article, we discuss the 5 most volatile stocks to buy now. If you want to read about some more volatile stocks, go directly to 15 Most Volatile Stocks to Buy Now. 5. Omnicell, Inc. (NASDAQ:OMCL) Number of Hedge Fund Holders: 23 52-Week Price Range ($): 46.19 – 187.29 Omnicell, Inc. (NASDAQ:OMCL) provides […]
Omnicell to Release Third Quarter 2022 Financial Results on November 2, 2022 2022/10/13 20:01:00 Business Wire
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Release Third Quarter 2022 Financial Results on November 2, 2022
Omnicell launches Specialty Pharmacy Services 2022/10/11 13:25:29 Seeking Alpha
Omnicell (OMCL) said it launched Specialty Pharmacy Services to support optimized outpatient medication management.Specialty Pharmacy Services is an offering to help health systems…
Omnicell says advance services to drive profitable growth in long-run: Investor Day 2022/09/20 20:37:59 Seeking Alpha
Omnicell (OMCL) sees its transformation to advance service business model to reap in the long-run with contribution of ~20% to 30% of total revenue by 2025, the…
Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day 2022/09/20 20:01:00 Wallstreet:Online
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication management and adherence tools for health systems and pharmacies, held its 2022 Investor Day today and provided an in-depth overview of the Company’s differentiated strategy and unique business model, as well as its Advanced Services portfolio, ESG strategy, and provided more details on its long-term
Buy this niche health care tech leader as pharmacies shift toward automation, Bank of America says 2022/09/09 12:05:58 CNBC
It''s a good time for investors to load up on shares of Omnicell as the pharmacy industry turns toward automation, Bank of America says
Omnicell says advance services to drive profitable growth in long-run: Investor Day 2022/09/20 20:37:59 Seeking Alpha
Omnicell (OMCL) sees its transformation to advance service business model to reap in the long-run with contribution of ~20% to 30% of total revenue by 2025, the…
Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day 2022/09/20 20:01:00 Wallstreet:Online
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication management and adherence tools for health systems and pharmacies, held its 2022 Investor Day today and provided an in-depth overview of the Company’s differentiated strategy and unique business model, as well as its Advanced Services portfolio, ESG strategy, and provided more details on its long-term
Buy this niche health care tech leader as pharmacies shift toward automation, Bank of America says 2022/09/09 12:05:58 CNBC
It''s a good time for investors to load up on shares of Omnicell as the pharmacy industry turns toward automation, Bank of America says